Lytic CD8+ T cells at the psoriasis plaque’s epidermis secrete IL-17, IL-21 and IL-22 and depends on autocrine TNFalpha production. IL-17-producing CD4+ T lymphocytes (Th17) are currently considered relevant participants in the pathogenesis of psoriasis skin lesions. However, little is known about the potential role of IL-17-producing CD8+ T cells, which are also present at the psoriatic plaque. We have addressed the functional characterization of this CD8+ subtype of T lymphocytes from psoriasis patients. Our results show that CD8+IL-17+ cells from psoriasis-inflamed skin tissue produce TNF-α and IFN-γ (Th1-related cytokines) as well as IL-17, IL-21, and IL-22 (Th17-related cytokines) efficiently. A significant up-regulation of the RORC transcription factor is also observed. These cells are refractory to Tregs but show a proliferative response to anti-CD3/CD28 stimulation that is enhanced by IL-12 and IL-15. Blocking of TNF-α activity inhibits TCR-mediated activation and IL-17 production. CD8+IL-17+ T cells are cytotoxic cells that display TCR/CD3-mediated cytotoxic abilities to kill target cells. Thus, CD8+IL-17+ T cells share some key features with Th17 cells and exhibit remarkable differential abilities attributable to the CD8+ lineage of T lymphocytes, adding new insights into the functional resources of IL-17-producing cells from human epidermis that could be of potential interest to our understanding of the pathogenesis of psoriasis.
1 September 2020 in The Journal of Allergy and Clinical Immunology: In Practice
We investigated the ability of human peripheral CD4+ cellsto express CD94 and NKG2 molecules as a consequence ofCD3-mediated activation. Using highly purified peripheralCD4+ T cells, we found expression of both CD94 and NKG2A 15days after CD3-mediated stimulation of cells. We also determined byreverse transcriptase-PCR that all gene members of NKG2 family—namely,NKG2A, -C, -D, and -E—are sequentially expressed on CD4+cells. We found that this expression is tightly regulated by cytokines,and we identified transforming growth factor-β1 and interleukin-10 asthe main factors that, on CD3-dependent stimulation, positivelycontribute to the expression of CD94 and NKG2A on CD4+cells. We also investigated the functional role of NKG2A and found thatcoligation of CD3 and NKG2A by specific monoclonal antibodies resultsin significant inhibition of interferon γ and tumor necrosis factorα production by stimulated CD4+ cells. The presence andfunction of these receptors on CD4+ lymphocytes support amore general role for NKG2 molecules, whose functions were originallythought to be confined to cytotoxic cells, in the immune system.